одобрен

Приложение 2 на ПЛС от 02.12.2019 г.

Уникален идентификатор:  e2c4f263-c723-41f2-96a5-2da265b9c4bf

Текуща версия: 1

Показвана версия: 1

Формат: CSV

  • Създаден на: 2019-12-03 10:27:26
  • Създаден от: georgi_sivchev
  • Последна промяна: 2019-12-03 10:27:26
записа на страница

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

J07AL02 Pneumococcus, purified polysaccharides antigen Prevenar Suspension for injection pneumococcal polysaccharide serotype 4 - 2 mcg; pneumococcal polysaccharide serotype 6B - 4 mcg; pneumococcal polysaccharide serotype 9V - 2 mcg; pneumococcal polysaccharide serotype 14 - 2 mcg; pneumococcal oligosaccharide serotype 18c - 2 mcg; pneumococ mg 1 Pfizer Limited, Обединено Кралство - 96.61 96.61 100% Съгласно РУ № 255/ 04.11.2011; КЦPP-1460/02.10.2012 г.; КЦPP-970/16.07.2012 г.; НСР-619/23.07.2013; НСР-3412/30.04.2014 02.06.2014 08.09.2012 Заличен 2009
J07AL02 Pneumococcal saccharide conjugated vaccine, absorbed J07AL02 Pneumococcal saccharide conjugated vaccine, absorbed
J07AL02 Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated Prevenar 13 Suspension for injection 0.5 ml 1 pre-fylled syringe Pfizer Limited, Обединено Кралство 0.5 mg 106.13 106.13 106.13 100% Z23.8 КЦРР-2795/20.03.2013; НСР-2500/24.01.2014; НСР-628/23.07.2013 и КП-46/21.05.2014; НСР-7253/21.10.2015. 16.11.2015 Заличен 2862
J07AL52 Pneumococcal polysaccharide conjugate vaccine J07AL52 Pneumococcal polysaccharide conjugate vaccine
J07AL52 Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated SYNFLORIX Suspension for injection 0.5 ml 1 prefilled syringe + 2 needles GlaxoSmithKline Biologicals S.A., Белгия 1 dose 76.84 76.84 76.84 100% Съгласно РУ НСР-16866/28.09.2018 02.11.2018 Активен 16291
J07AL52 Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated SYNFLORIX Suspension for injection 0.5 ml 1 pre-filled syringe + 1 needle GlaxoSmithKline Biologicals S.A., Белгия 1 dose 76.84 76.84 76.84 100% Съгласно РУ № 25/03.08.2009; № 89/17.06.2010; НСР-1281/25.09.2013; НСР-3842/16.06.2014 16.07.2014 08.09.2012 Активен 2958
J07BB02 Influenza vaccine (split virion, inactivated) J07BB02 Influenza vaccine (split virion, inactivated)
J07BB02 influenza, inactivated, split virus or surface antigen FLUARIX Suspension for injection 15 mcg haemagglutinin mg 1 pre-filled syringe 0.5 ml ГлаксоСмитКлайн ЕООД, България 1 dose 8.8 8.8 8.8 100% Съгласно РУ № 121/ 09.12.2010; КЦРР-2462/27.02.2013 г.; НСР-16501/17.08.2018 02.09.2018 08.09.2012 Заличен 1690
J07BB02 Influenza vaccine (split virion, inactivated) J07BB02 Influenza vaccine (split virion, inactivated)
J07BB02 influenza, inactivated, split virus or surface antigen VAXIGRIP Suspension for injection 0,5 ml 1 pre-filled syringe with attached needle Sanofi Pasteur S.A., Франция 1 dose 10.12 10.12 10.12 100% Съгласно РУ НСР-4242/30.07.2014; НСР-9783/14.07.2016 02.08.2016 Заличен 1926
J07BC01 Hepatit B antigen, purified J07BC01 Hepatit B antigen, purified
J07BC01 Hepatitis B, purified antigen Engerix B Suspension for injection 10 mcg/0.5 ml 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия 1 dose 15 15 15 100% Съгласно РУ № 209/ 04.11.2011; НСР-3980/30.06.2014; НСР-8323/26.02.2016; НСР-10750/27.10.2016; НСР-13274/20.07.2017; НСР-17028/19.10.2018; НСР-19079/27.06.2019 02.08.2019 08.09.2012 Активен 2998
J07BC01 Hepatitis B, purified antigen Engerix B Suspension for injection 20 mcg/1.0 ml 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия 1 dose 21.24 21.24 21.24 100% Съгласно РУ № 209/ 04.11.2011; КЦРР-2557/14.03.2013 г.; НСР-12476/28.04.2017 г.; НСР-16124/13.07.2018; НСР-18291/28.03.2019 02.05.2019 08.09.2012 Активен 1730
J07BC01 Hepatit B antigen, purified J07BC01 Hepatit B antigen, purified
J07BC01 Hepatitis B, purified antigen ENGERIX B Suspension for injection 20 mcg/1.0 ml - 1 dose mcg 1 GlaxoSmithKline Biologicals S.A., Белгия 1 dose - 26.08 26.08 100% Съгласно РУ № 86/ 17.06.2010; № 209/ 04.11.2011; КЦРР-1637/15.11.2012. 13.12.2012 08.09.2012 Заличен 907
J07BC02 Hepatitis A vaccine (inactivated, adsorbed) J07BC02 Hepatitis A vaccine (inactivated, adsorbed)
J07BC02 Hepatitis A, inactivated, whole virus Havrix 720 Suspension for injection 0.5ml (Junior monodose) 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия 1 dose 24.65 24.65 24.65 100% Съгласно РУ HCР-301/03.07.2013; КП-303/17.06.2015 и НСР-5955/01.04.2015 16.07.2015 08.09.2012 Активен 1925
J07BC02 Hepatitis A vaccine (inactivated, adsorbed) J07BC02 Hepatitis A vaccine (inactivated, adsorbed)
J07BC02 Hepatitis A, inactivated, whole virus AVAXIM 160 U adult susp. Inj. Pre-filled syringe 0, 5 ml Хепатит А вирус, щам GBM, инактивиран и адсорбиран ….. 160 единици ml 1 Sanofi Pasteur S.A., Франция - 43.42 43.42 100% Съгласно РУ НСР-4245/30.07.2014; НСР-9461/01.06.2016 02.07.2016 Заличен 1718
J07BC02 Hepatitis A, inactivated, whole virus AVAXIM 80 U pediatric susp. Inj. Pre-filled syringe 0, 5 ml Inactivated Hepatitis A virus (strain GMB) 80 U ml 1 Sanofi Pasteur S.A., Франция ml 29 29 100% Съгласно РУ НСР-4439/15.08.2014; НСР-9460/01.06.2016 02.07.2016 Заличен 1717
J07BC20 Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) J07BC20 Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
J07BC20 Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) TWINRIX ADULT Suspension for injection 1ml ml (1 dose = 1 ml) 1 pre-filled syringe + 1 separate needle GlaxoSmithKline Biologicals S.A., Белгия 1 ml (1dose=1 ml) 48.65 48.65 48.65 100% Съгласно РУ КЦРР-743/07.06.2012 г.; НСР-7782/28.12.2015 02.02.2016 08.09.2012 Активен 129
J07BC20 Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) TWINRIX ADULT Suspension for injection 20 mcg/1 ml 1 dose=1 ml 1 GlaxoSmithKline Biologicals S.A., Белгия 1 dose=1 ml ml 50.33 50.33 50.33 100% Съгласно РУ № 86/17.06.2010; КЦРР-1641/15.11.2012. 13.12.2012 08.09.2012 Заличен 1244
J07BD52 Measles, mumps and rubella vaccine, live J07BD52 Measles, mumps and rubella vaccine, live
J07BD52 Measles, mumps and rubella vaccine (live) Priorix Powder and solvent for suspension for injection 1 dose 0.5 ml 1 vial with powder + 1 pre-filled syr. 0,5 ml solv + 2 separate needles GlaxoSmithKline Biologicals S.A., Белгия 1 dose 19.03 18.66 18.66 100% Съгласно РУ КЦРР-718/07.06.2012 г. 16.11.2015 08.09.2012 Активен 1234
Показва 3375 до 3399 от общо 5912 записа
Линк за сваляне в CSV формат: Копирай
Линк за сваляне в JSON формат: Копирай
Линк за сваляне в XML формат: Копирай
 

Моля изчакайте